Literature DB >> 7846055

CD18 (beta 2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity.

A G Rosmarin1, D Caprio, R Levy, C Simkevich.   

Abstract

Normal cellular differentiation is linked to tightly regulated gene transcription. However, the DNA elements and trans-acting factors that regulate transcription in myeloid cells are poorly defined. CD18, the beta chain of the leukocyte integrins, is transcriptionally regulated during myeloid differentiation. The CD18 promoter is active after transfection into myeloid cells. We demonstrate that a region of the CD18 promoter that contains two binding sites for the PU.1 transcription factor is required for activity in myeloid cells. These sites are bound by in vitro translated PU.1 and by PU.1 from myeloid nuclear extracts. Mutagenesis of these sites abrogates binding by PU.1 and substantially decreases promoter activity in myeloid cells. Thus, the leukocyte-specific transcription factor PU.1 is required for myeloid activity of CD18.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7846055      PMCID: PMC42708          DOI: 10.1073/pnas.92.3.801

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element.

Authors:  S Dalton; R Treisman
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

2.  Characterization of the myeloid-specific CD11b promoter.

Authors:  H L Pahl; A G Rosmarin; D G Tenen
Journal:  Blood       Date:  1992-02-15       Impact factor: 22.113

Review 3.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

Authors:  P J Mitchell; R Tjian
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

4.  The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene.

Authors:  M J Klemsz; S R McKercher; A Celada; C Van Beveren; R A Maki
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

Review 5.  The CD11/CD18 leukocyte glycoprotein deficiency.

Authors:  R F Todd; D R Freyer
Journal:  Hematol Oncol Clin North Am       Date:  1988-03       Impact factor: 3.722

6.  Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing.

Authors:  S Henikoff
Journal:  Gene       Date:  1984-06       Impact factor: 3.688

7.  Genomic organization and chromosomal localization of the human cathepsin G gene.

Authors:  P A Hohn; N C Popescu; R D Hanson; G Salvesen; T J Ley
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

8.  Differential expression of CD11b/CD18 (Mo1) and myeloperoxidase genes during myeloid differentiation.

Authors:  A G Rosmarin; S C Weil; G L Rosner; J D Griffin; M A Arnaout; D G Tenen
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Detection of two tissue-specific DNA-binding proteins with affinity for sites in the mouse beta-globin intervening sequence 2.

Authors:  D L Galson; D E Housman
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

View more
  16 in total

1.  TIF1beta functions as a coactivator for C/EBPbeta and is required for induced differentiation in the myelomonocytic cell line U937.

Authors:  J W Rooney; K L Calame
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

2.  Control of myeloid-specific integrin alpha Mbeta 2 (CD11b/CD18) expression by cytokines is regulated by Stat3-dependent activation of PU.1.

Authors:  Athanasia D Panopoulos; David Bartos; Ling Zhang; Stephanie S Watowich
Journal:  J Biol Chem       Date:  2002-03-11       Impact factor: 5.157

Review 3.  Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Authors:  Hisham Abdel-Azim; Weili Sun; Lingtao Wu
Journal:  Pharmacol Ther       Date:  2019-08-27       Impact factor: 12.310

4.  Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities.

Authors:  S R McKercher; B E Torbett; K L Anderson; G W Henkel; D J Vestal; H Baribault; M Klemsz; A J Feeney; G E Wu; C J Paige; R A Maki
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

Review 5.  IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.

Authors:  Muhammad Babar Khawar; Maryam Mukhtar; Muddasir Hassan Abbasi; Nadeem Sheikh
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

6.  GA-binding protein and p300 are essential components of a retinoic acid-induced enhanceosome in myeloid cells.

Authors:  Karen K Resendes; Alan G Rosmarin
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

7.  c-Jun homodimers can function as a context-specific coactivator.

Authors:  Benoit Grondin; Martin Lefrancois; Mathieu Tremblay; Marianne Saint-Denis; André Haman; Kazuo Waga; André Bédard; Daniel G Tenen; Trang Hoang
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

8.  Cooperative Activity of GABP with PU.1 or C/EBPε Regulates Lamin B Receptor Gene Expression, Implicating Their Roles in Granulocyte Nuclear Maturation.

Authors:  Krishnakumar Malu; Rahul Garhwal; Margery G H Pelletier; Deepali Gotur; Stephanie Halene; Monika Zwerger; Zhong-Fa Yang; Alan G Rosmarin; Peter Gaines
Journal:  J Immunol       Date:  2016-06-24       Impact factor: 5.422

9.  Transcription factor PU.1 mediates induction of c-fms in vascular smooth muscle cells: a mechanism for phenotypic change to phagocytic cells.

Authors:  T Inaba; T Gotoda; S Ishibashi; K Harada; J I Ohsuga; K Ohashi; Y Yazaki; N Yamada
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

10.  Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression.

Authors:  Tianqing Kong; Holger K Eltzschig; Jorn Karhausen; Sean P Colgan; C Simon Shelley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.